IRE for the treatment of pancreatic cancer (IPG442)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on IRE for the treatment of pancreatic cancer.
Irreversible electroporation is a process that uses electrical pulses to kill cancer cells. It is applied directly to a pancreatic cancer tumour through special needles. The main difference between this procedure and thermal techniques for destroying tumours is that it does not produce extreme heat or cold. This means that it may cause less damage to healthy surrounding tissues than some other procedures.
J66.8 Other specified therapeutic percutaneous operations on pancreas
Y13.8 Other specified other destruction of lesion of organ NOC
Y53.- Approach to organ under image control
This page was last updated: 09 September 2013
- Web format
- Full Guidance (PDF)
- IPG442 Trin canser pancreatig gan ddefnyddio curiadau trydan ynni-uchel anthermol: Gwybodaeth i'r cyhoedd (fformat MS Word)
Information for the public
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.